Opzelura (ruxolitinib cream) - Incyte
Translating ruxolitinib cream data for moderate AD into clinical practice (EADV 2026) - Aug 29, 2026 - Abstract #SAT 10.06.03; Pres time: Oct 2, 2026; 01:35 PM - 01:50 PM; Location: Hall M; "This session is sponsored by: Incyte Biosciences International Sàrl" 
Clinical • Atopic Dermatitis • Dermatitis • Dermatology • Dermatopathology • Immunology
https://pagv3.virtual-meeting.org/eadv/eadvcongress2026/en-GB/pag/presentation/61675
 
Vimal H. Prajapati
 
Aug 29, 2026
 
Prev Next